Share Price and Basic Stock Data
Last Updated: January 28, 2026, 3:15 pm
| PEG Ratio | 2.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambuja Cements Ltd, a leading player in the Indian cement industry, reported a market capitalization of ₹1,32,205 Cr and a current share price of ₹535. The company demonstrated a robust growth trajectory with reported sales of ₹38,937 Cr for the trailing twelve months (TTM) ending in March 2023, which rose to ₹35,045 Cr in March 2025. This growth trend reflects a strong demand for cement, with quarterly sales peaking at ₹10,289 Cr in June 2025. The company’s operational performance has been bolstered by strategic initiatives and a favorable market environment, enabling it to maintain a competitive edge. The operating profit margin (OPM) stood at 19% in the latest reporting period, indicating efficient cost management. The sales figures for the last quarter of September 2023 were ₹7,424 Cr, showcasing seasonal fluctuations yet remaining above previous quarters, indicating sustained demand in the market.
Profitability and Efficiency Metrics
Ambuja Cements has reported solid profitability metrics, with a net profit of ₹7,222 Cr and a return on equity (ROE) of 8.73%. The company’s operating profit margins have shown an upward trend, with an OPM of 19% in the most recent quarter, reflecting effective operational management. The interest coverage ratio (ICR) reported at an impressive 45.06x indicates the firm’s strong ability to meet interest obligations, significantly above typical sector levels. However, net profit margins exhibited variability, with the latest margin recorded at 14.68%. Other efficiencies, such as the cash conversion cycle (CCC), stood at 100 days, suggesting room for improvement in working capital management. The reported inventory turnover ratio of 8.92x highlights effective inventory management relative to sales, positioning the company favorably against industry norms.
Balance Sheet Strength and Financial Ratios
Ambuja Cements’ balance sheet reflects significant strength, with total assets reported at ₹80,941 Cr and total liabilities at ₹80,941 Cr as of March 2025. The company’s reserves have grown substantially, reaching ₹55,752 Cr, while borrowings stood at ₹1,271 Cr, indicating a conservative leverage approach. The price-to-book value (P/BV) ratio of 2.96x suggests that while the company is well-capitalized, it may be slightly overvalued compared to its book value. The current ratio of 1.42x indicates adequate liquidity to cover short-term liabilities, which is favorable compared to industry standards. Moreover, the company has maintained a consistent dividend payout ratio, reported at 11.82%, reflecting a commitment to returning value to shareholders while retaining earnings for growth.
Shareholding Pattern and Investor Confidence
The shareholding structure of Ambuja Cements demonstrates solid promoter confidence, with promoters holding 67.68% of the shares as of September 2025, a slight increase from 63.22% in December 2022. This increase in promoter stake can be interpreted as a positive signal of long-term commitment to the company. Foreign Institutional Investors (FIIs) have reduced their stake to 5.91%, while Domestic Institutional Investors (DIIs) have increased their holdings to 19.41%, reflecting a shift in investor sentiment. The public shareholding remained stable at 6.77%, with a total of 6,20,457 shareholders reported. This stable shareholding pattern indicates a balanced interest among various investor categories, contributing to investor confidence in the company’s prospects.
Outlook, Risks, and Final Insight
Looking ahead, Ambuja Cements is well-positioned to capitalize on the ongoing growth in the Indian infrastructure sector, which is expected to drive cement demand. However, risks include potential fluctuations in raw material prices and regulatory challenges that could impact profitability. The company’s strong financial metrics, including a high ICR and robust margins, suggest resilience in navigating these challenges. Furthermore, the increasing promoter stake may enhance investor confidence. Nevertheless, the decline in FII participation could signal caution among foreign investors. Ambuja Cements must focus on maintaining operational efficiency and managing working capital effectively to sustain its competitive advantage in the expanding market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,75,203 Cr. | 12,733 | 13,102/10,048 | 48.3 | 2,444 | 0.62 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,221 Cr. | 1,067 | 1,209/788 | 131 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,666 Cr. | 441 | 490/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,785 Cr. | 217 | 309/197 | 29.0 | 74.4 | 0.47 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,679.73 Cr | 1,954.45 | 36.27 | 573.47 | 0.57% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,143 | 7,907 | 7,966 | 8,713 | 7,424 | 8,129 | 8,894 | 8,392 | 7,552 | 9,329 | 9,981 | 10,289 | 9,174 |
| Expenses | 6,809 | 6,885 | 6,727 | 7,046 | 6,122 | 6,397 | 7,195 | 7,112 | 6,441 | 7,617 | 8,113 | 8,328 | 7,414 |
| Operating Profit | 334 | 1,021 | 1,239 | 1,667 | 1,302 | 1,732 | 1,699 | 1,280 | 1,111 | 1,712 | 1,868 | 1,961 | 1,761 |
| OPM % | 5% | 13% | 16% | 19% | 18% | 21% | 19% | 15% | 15% | 18% | 19% | 19% | 19% |
| Other Income | 75 | -18 | 142 | 268 | 480 | 204 | 448 | 358 | 220 | 1,355 | 713 | 300 | 39 |
| Interest | 41 | 43 | 39 | 52 | 61 | 70 | 93 | 68 | 67 | 67 | 14 | 67 | 77 |
| Depreciation | 331 | 337 | 352 | 372 | 381 | 416 | 459 | 476 | 520 | 664 | 786 | 798 | 885 |
| Profit before tax | 39 | 623 | 989 | 1,512 | 1,340 | 1,450 | 1,595 | 1,094 | 744 | 2,336 | 1,780 | 1,396 | 838 |
| Tax % | -33% | 22% | 23% | 25% | 26% | 25% | 5% | 28% | 33% | -12% | 28% | 27% | -175% |
| Net Profit | 51 | 488 | 763 | 1,135 | 987 | 1,091 | 1,521 | 783 | 496 | 2,620 | 1,282 | 1,017 | 2,302 |
| EPS in Rs | 0.47 | 2.19 | 3.25 | 4.56 | 3.99 | 4.15 | 4.78 | 2.60 | 1.95 | 8.59 | 3.88 | 3.39 | 7.14 |
Last Updated: January 2, 2026, 12:37 pm
Below is a detailed analysis of the quarterly data for Ambuja Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9,174.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,289.00 Cr. (Jun 2025) to 9,174.00 Cr., marking a decrease of 1,115.00 Cr..
- For Expenses, as of Sep 2025, the value is 7,414.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8,328.00 Cr. (Jun 2025) to 7,414.00 Cr., marking a decrease of 914.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 1,761.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,961.00 Cr. (Jun 2025) to 1,761.00 Cr., marking a decrease of 200.00 Cr..
- For OPM %, as of Sep 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 19.00%.
- For Other Income, as of Sep 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 300.00 Cr. (Jun 2025) to 39.00 Cr., marking a decrease of 261.00 Cr..
- For Interest, as of Sep 2025, the value is 77.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67.00 Cr. (Jun 2025) to 77.00 Cr., marking an increase of 10.00 Cr..
- For Depreciation, as of Sep 2025, the value is 885.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 798.00 Cr. (Jun 2025) to 885.00 Cr., marking an increase of 87.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 838.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,396.00 Cr. (Jun 2025) to 838.00 Cr., marking a decrease of 558.00 Cr..
- For Tax %, as of Sep 2025, the value is -175.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to -175.00%, marking a decrease of 202.00%.
- For Net Profit, as of Sep 2025, the value is 2,302.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,017.00 Cr. (Jun 2025) to 2,302.00 Cr., marking an increase of 1,285.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 7.14. The value appears strong and on an upward trend. It has increased from 3.39 (Jun 2025) to 7.14, marking an increase of 3.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:40 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,161 | 9,955 | 9,437 | 20,094 | 23,609 | 26,041 | 27,104 | 24,516 | 28,965 | 38,937 | 33,160 | 35,045 | 38,773 |
| Expenses | 7,492 | 8,022 | 7,895 | 16,913 | 19,751 | 22,030 | 22,507 | 19,511 | 22,755 | 33,815 | 26,760 | 29,074 | 31,471 |
| Operating Profit | 1,669 | 1,934 | 1,542 | 3,181 | 3,858 | 4,011 | 4,597 | 5,006 | 6,210 | 5,122 | 6,400 | 5,971 | 7,301 |
| OPM % | 18% | 19% | 16% | 16% | 16% | 15% | 17% | 20% | 21% | 13% | 19% | 17% | 19% |
| Other Income | 390 | 419 | 353 | 441 | 335 | 232 | 601 | 288 | 252 | 447 | 1,401 | 2,646 | 2,407 |
| Interest | 67 | 66 | 92 | 153 | 206 | 170 | 170 | 140 | 146 | 195 | 276 | 216 | 225 |
| Depreciation | 494 | 513 | 630 | 1,461 | 1,219 | 1,154 | 1,153 | 1,162 | 1,152 | 1,645 | 1,628 | 2,478 | 3,134 |
| Profit before tax | 1,498 | 1,774 | 1,173 | 2,008 | 2,768 | 2,919 | 3,875 | 3,992 | 5,164 | 3,729 | 5,896 | 5,922 | 6,349 |
| Tax % | 15% | 16% | 31% | 29% | 30% | -2% | 28% | 22% | 28% | 19% | 20% | 13% | |
| Net Profit | 1,278 | 1,487 | 808 | 1,434 | 1,945 | 2,973 | 2,783 | 3,107 | 3,711 | 3,024 | 4,735 | 5,158 | 7,222 |
| EPS in Rs | 8.27 | 9.59 | 5.21 | 5.57 | 7.64 | 10.97 | 10.55 | 11.91 | 14.00 | 13.01 | 16.26 | 16.92 | 23.00 |
| Dividend Payout % | 44% | 46% | 54% | 50% | 47% | 14% | 14% | 151% | 45% | 19% | 12% | 12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 8.93% |
| Change in YoY Net Profit Growth (%) | 0.00% |
Ambuja Cements Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 22% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 4, 2025, 11:10 pm
Balance Sheet
Last Updated: December 4, 2025, 12:56 am
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 309 | 310 | 310 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 440 | 493 | 494 |
| Reserves | 9,153 | 9,760 | 9,961 | 19,424 | 20,275 | 21,973 | 23,681 | 22,360 | 24,957 | 31,301 | 41,012 | 52,951 | 55,752 |
| Borrowings | 48 | 34 | 35 | 29 | 24 | 40 | 41 | 471 | 477 | 523 | 699 | 788 | 1,271 |
| Other Liabilities | 3,446 | 3,774 | 3,827 | 12,974 | 14,813 | 14,981 | 16,059 | 16,490 | 19,374 | 19,501 | 22,916 | 26,709 | 31,193 |
| Total Liabilities | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 | 88,710 |
| Fixed Assets | 6,147 | 6,310 | 6,170 | 21,410 | 20,898 | 20,636 | 20,701 | 20,486 | 22,254 | 23,551 | 32,194 | 42,578 | 56,540 |
| CWIP | 698 | 692 | 416 | 582 | 667 | 1,008 | 1,554 | 2,422 | 2,168 | 2,526 | 2,658 | 9,886 | 10,473 |
| Investments | 1,714 | 2,097 | 2,149 | 175 | 153 | 133 | 150 | 167 | 198 | 214 | 849 | 1,912 | 104 |
| Other Assets | 4,399 | 4,780 | 5,398 | 10,657 | 13,791 | 15,613 | 17,773 | 16,643 | 20,585 | 25,430 | 29,365 | 26,566 | 21,594 |
| Total Assets | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 | 88,710 |
Below is a detailed analysis of the balance sheet data for Ambuja Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 494.00 Cr.. The value appears strong and on an upward trend. It has increased from 493.00 Cr. (Mar 2025) to 494.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 55,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 52,951.00 Cr. (Mar 2025) to 55,752.00 Cr., marking an increase of 2,801.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,271.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 788.00 Cr. (Mar 2025) to 1,271.00 Cr., marking an increase of 483.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 31,193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26,709.00 Cr. (Mar 2025) to 31,193.00 Cr., marking an increase of 4,484.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 88,710.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80,941.00 Cr. (Mar 2025) to 88,710.00 Cr., marking an increase of 7,769.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 56,540.00 Cr.. The value appears strong and on an upward trend. It has increased from 42,578.00 Cr. (Mar 2025) to 56,540.00 Cr., marking an increase of 13,962.00 Cr..
- For CWIP, as of Sep 2025, the value is 10,473.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,886.00 Cr. (Mar 2025) to 10,473.00 Cr., marking an increase of 587.00 Cr..
- For Investments, as of Sep 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,912.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 1,808.00 Cr..
- For Other Assets, as of Sep 2025, the value is 21,594.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26,566.00 Cr. (Mar 2025) to 21,594.00 Cr., marking a decrease of 4,972.00 Cr..
- For Total Assets, as of Sep 2025, the value is 88,710.00 Cr.. The value appears strong and on an upward trend. It has increased from 80,941.00 Cr. (Mar 2025) to 88,710.00 Cr., marking an increase of 7,769.00 Cr..
Notably, the Reserves (55,752.00 Cr.) exceed the Borrowings (1,271.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -47.00 | -33.00 | -34.00 | -26.00 | -21.00 | -36.00 | -37.00 | -466.00 | -471.00 | 5.00 | -693.00 | -783.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 8 | 11 | 17 | 14 | 18 | 14 | 8 | 8 | 11 | 13 | 17 |
| Inventory Days | 419 | 379 | 394 | 339 | 323 | 333 | 208 | 193 | 337 | 234 | 238 | 238 |
| Days Payable | 251 | 265 | 299 | 324 | 370 | 339 | 231 | 259 | 359 | 198 | 196 | 154 |
| Cash Conversion Cycle | 176 | 123 | 107 | 32 | -33 | 13 | -9 | -58 | -14 | 46 | 56 | 100 |
| Working Capital Days | -54 | -61 | -65 | -67 | -62 | -34 | -56 | -80 | -74 | 45 | 8 | -22 |
| ROCE % | 16% | 18% | 11% | 11% | 12% | 12% | 14% | 14% | 17% | 12% | 13% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Large Cap Fund | 22,293,419 | 3.05 | 1240.29 | N/A | N/A | N/A |
| Mirae Asset Large Cap Fund | 11,409,235 | 1.52 | 634.75 | 9,478,894 | 2025-12-07 02:57:30 | 20.36% |
| HDFC Balanced Advantage Fund | 8,225,056 | 0.42 | 457.6 | N/A | N/A | N/A |
| ICICI Prudential Equity & Debt Fund | 7,534,658 | 0.84 | 419.19 | N/A | N/A | N/A |
| Kotak Flexicap Fund | 7,000,000 | 0.69 | 389.45 | 7,800,000 | 2025-12-15 02:16:40 | -10.26% |
| Mirae Asset ELSS Tax Saver Fund | 5,593,546 | 1.14 | 311.2 | 6,828,859 | 2025-12-08 05:06:49 | -18.09% |
| ICICI Prudential Equity Savings Fund | 5,168,100 | 1.59 | 287.53 | 5,045,250 | 2025-12-15 04:16:45 | 2.43% |
| HDFC Large and Mid Cap Fund | 4,949,329 | 0.95 | 275.36 | N/A | N/A | N/A |
| HDFC Manufacturing Fund | 4,900,000 | 2.48 | 272.61 | N/A | N/A | N/A |
| Invesco India Contra Fund | 4,127,441 | 1.11 | 229.63 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 17.00 | 17.99 | 13.01 | 14.00 | 11.91 |
| Diluted EPS (Rs.) | 16.96 | 16.67 | 12.64 | 14.00 | 11.91 |
| Cash EPS (Rs.) | 30.95 | 28.84 | 23.37 | 24.39 | 21.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Revenue From Operations / Share (Rs.) | 142.28 | 150.88 | 196.09 | 145.87 | 123.47 |
| PBDIT / Share (Rs.) | 35.02 | 34.43 | 29.51 | 33.05 | 27.47 |
| PBIT / Share (Rs.) | 24.95 | 27.04 | 21.23 | 27.25 | 21.62 |
| PBT / Share (Rs.) | 23.99 | 26.74 | 18.64 | 25.91 | 20.03 |
| Net Profit / Share (Rs.) | 20.89 | 21.45 | 15.09 | 18.59 | 15.57 |
| NP After MI And SOA / Share (Rs.) | 16.92 | 16.27 | 13.01 | 14.00 | 11.91 |
| PBDIT Margin (%) | 24.61 | 22.81 | 15.05 | 22.65 | 22.25 |
| PBIT Margin (%) | 17.53 | 17.92 | 10.82 | 18.67 | 17.51 |
| PBT Margin (%) | 16.86 | 17.72 | 9.50 | 17.75 | 16.22 |
| Net Profit Margin (%) | 14.68 | 14.21 | 7.69 | 12.74 | 12.61 |
| NP After MI And SOA Margin (%) | 11.89 | 10.78 | 6.63 | 9.59 | 9.64 |
| Return on Networth / Equity (%) | 7.79 | 8.62 | 8.14 | 10.96 | 10.39 |
| Return on Capital Employeed (%) | 9.16 | 11.17 | 10.48 | 15.92 | 14.09 |
| Return On Assets (%) | 5.14 | 5.47 | 4.99 | 6.15 | 5.95 |
| Asset Turnover Ratio (%) | 0.47 | 0.56 | 0.49 | 0.41 | 0.34 |
| Current Ratio (X) | 1.42 | 2.05 | 1.67 | 1.52 | 1.38 |
| Quick Ratio (X) | 1.12 | 1.75 | 1.39 | 1.27 | 1.20 |
| Inventory Turnover Ratio (X) | 8.92 | 3.61 | 3.51 | 2.93 | 2.20 |
| Dividend Payout Ratio (NP) (%) | 11.82 | 13.87 | 48.42 | 0.00 | 142.70 |
| Dividend Payout Ratio (CP) (%) | 7.41 | 9.54 | 29.58 | 0.00 | 95.70 |
| Earning Retention Ratio (%) | 88.18 | 86.13 | 51.58 | 0.00 | -42.70 |
| Cash Earning Retention Ratio (%) | 92.59 | 90.46 | 70.42 | 0.00 | 4.30 |
| Interest Coverage Ratio (X) | 39.94 | 27.38 | 30.07 | 45.06 | 38.90 |
| Interest Coverage Ratio (Post Tax) (X) | 24.93 | 17.29 | 18.01 | 27.17 | 24.31 |
| Enterprise Value (Cr.) | 136725.29 | 132923.92 | 76710.60 | 70462.46 | 46861.76 |
| EV / Net Operating Revenue (X) | 3.90 | 4.01 | 1.97 | 2.43 | 1.91 |
| EV / EBITDA (X) | 15.85 | 17.57 | 13.09 | 10.74 | 8.59 |
| MarketCap / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| Retention Ratios (%) | 88.17 | 86.12 | 51.57 | 0.00 | -42.70 |
| Price / BV (X) | 2.48 | 3.25 | 2.29 | 2.96 | 2.17 |
| Price / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Ambuja Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.00. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.00, marking a decrease of 0.99.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 16.96, marking an increase of 0.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 28.84 (Mar 24) to 30.95, marking an increase of 2.11.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.28. It has decreased from 150.88 (Mar 24) to 142.28, marking a decrease of 8.60.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.02. This value is within the healthy range. It has increased from 34.43 (Mar 24) to 35.02, marking an increase of 0.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 24.95. This value is within the healthy range. It has decreased from 27.04 (Mar 24) to 24.95, marking a decrease of 2.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.99. This value is within the healthy range. It has decreased from 26.74 (Mar 24) to 23.99, marking a decrease of 2.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.89. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 20.89, marking a decrease of 0.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.92. This value is within the healthy range. It has increased from 16.27 (Mar 24) to 16.92, marking an increase of 0.65.
- For PBDIT Margin (%), as of Mar 25, the value is 24.61. This value is within the healthy range. It has increased from 22.81 (Mar 24) to 24.61, marking an increase of 1.80.
- For PBIT Margin (%), as of Mar 25, the value is 17.53. This value is within the healthy range. It has decreased from 17.92 (Mar 24) to 17.53, marking a decrease of 0.39.
- For PBT Margin (%), as of Mar 25, the value is 16.86. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 16.86, marking a decrease of 0.86.
- For Net Profit Margin (%), as of Mar 25, the value is 14.68. This value exceeds the healthy maximum of 10. It has increased from 14.21 (Mar 24) to 14.68, marking an increase of 0.47.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from 10.78 (Mar 24) to 11.89, marking an increase of 1.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.79. This value is below the healthy minimum of 15. It has decreased from 8.62 (Mar 24) to 7.79, marking a decrease of 0.83.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 11.17 (Mar 24) to 9.16, marking a decrease of 2.01.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has decreased from 5.47 (Mar 24) to 5.14, marking a decrease of 0.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.56 (Mar 24) to 0.47, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 2.05 (Mar 24) to 1.42, marking a decrease of 0.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.12, marking a decrease of 0.63.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.92. This value exceeds the healthy maximum of 8. It has increased from 3.61 (Mar 24) to 8.92, marking an increase of 5.31.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.82. This value is below the healthy minimum of 20. It has decreased from 13.87 (Mar 24) to 11.82, marking a decrease of 2.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 20. It has decreased from 9.54 (Mar 24) to 7.41, marking a decrease of 2.13.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.18. This value exceeds the healthy maximum of 70. It has increased from 86.13 (Mar 24) to 88.18, marking an increase of 2.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.59. This value exceeds the healthy maximum of 70. It has increased from 90.46 (Mar 24) to 92.59, marking an increase of 2.13.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 39.94. This value is within the healthy range. It has increased from 27.38 (Mar 24) to 39.94, marking an increase of 12.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 24.93. This value is within the healthy range. It has increased from 17.29 (Mar 24) to 24.93, marking an increase of 7.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 136,725.29. It has increased from 132,923.92 (Mar 24) to 136,725.29, marking an increase of 3,801.37.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 4.01 (Mar 24) to 3.90, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 15.85. This value exceeds the healthy maximum of 15. It has decreased from 17.57 (Mar 24) to 15.85, marking a decrease of 1.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For Retention Ratios (%), as of Mar 25, the value is 88.17. This value exceeds the healthy maximum of 70. It has increased from 86.12 (Mar 24) to 88.17, marking an increase of 2.05.
- For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 3.25 (Mar 24) to 2.48, marking a decrease of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambuja Cements Ltd:
- Net Profit Margin: 14.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.16% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.79% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 24.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.12
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23 (Industry average Stock P/E: 36.27)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Adani Corporate House, Shantigram, Near Vaishnavdevi Circle, Ahmedabad Gujarat 382421 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gautam Adani | NonExeChairman&NonInd.Director |
| Mr. Ajay Kapur | Managing Director |
| Mr. Vinod Bahety | WholeTime Director & CEO |
| Mr. Karan Adani | Non Exe.Non Ind.Director |
| Mr. M R Kumar | Non Exe.Non Ind.Director |
| Mr. Rajnish Kumar | Ind. Non-Executive Director |
| Mr. Maheswar Sahu | Ind. Non-Executive Director |
| Ms. Purvi Sheth | Ind. Non-Executive Director |
| Mr. Ameet Desai | Ind. Non-Executive Director |
| Mr. Praveen Garg | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Ambuja Cements Ltd?
Ambuja Cements Ltd's intrinsic value (as of 28 January 2026) is ₹406.00 which is 24.11% lower the current market price of ₹535.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,32,205 Cr. market cap, FY2025-2026 high/low of ₹625/455, reserves of ₹55,752 Cr, and liabilities of ₹88,710 Cr.
What is the Market Cap of Ambuja Cements Ltd?
The Market Cap of Ambuja Cements Ltd is 1,32,205 Cr..
What is the current Stock Price of Ambuja Cements Ltd as on 28 January 2026?
The current stock price of Ambuja Cements Ltd as on 28 January 2026 is ₹535.
What is the High / Low of Ambuja Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambuja Cements Ltd stocks is ₹625/455.
What is the Stock P/E of Ambuja Cements Ltd?
The Stock P/E of Ambuja Cements Ltd is 23.0.
What is the Book Value of Ambuja Cements Ltd?
The Book Value of Ambuja Cements Ltd is 228.
What is the Dividend Yield of Ambuja Cements Ltd?
The Dividend Yield of Ambuja Cements Ltd is 0.38 %.
What is the ROCE of Ambuja Cements Ltd?
The ROCE of Ambuja Cements Ltd is 10.5 %.
What is the ROE of Ambuja Cements Ltd?
The ROE of Ambuja Cements Ltd is 8.73 %.
What is the Face Value of Ambuja Cements Ltd?
The Face Value of Ambuja Cements Ltd is 2.00.
